Archive for the ‘lysosomal enzymes’ Category

Fabrazyme

Fabrazyme

Generic Name: agalsidase beta (a GAL sih daze BAY tah)

What is Fabrazyme?

Fabrazyme is a man-made form of the naturally-occurring enzyme a-galactosidase A. A deficiency of the enzyme a-galactosidase A is called Fabry disease. It reduces deposits of globotriaosylceramide (GL-3) in the kidneys and other certain other cells in the body.

Fabrazyme is used in the treatment of Fabry disease.

Fabrazyme may also be used for purposes other than those listed here.

Important information about Fabrazyme

Symptoms of allergic or infusion reactions including difficulty breathing; closing of the throat; hives; rash; itching; fever; shaking; chest tightness; high or low blood pressure; fast heartbeats; muscle pain; stomach pain; nausea or vomiting; dizziness; numbness or tingling; and headache have occurred upon injection of Fabrazyme in many patients. Most patients treated with Fabrazyme develop antibodies to agalsidase beta and many will develop symptoms of an infusion reaction. A slow rate of injection of the medication and pretreatment with other medications may decrease the severity of these symptoms. Emergency medical attention may be required if a severe allergic reaction is experienced.

Before using Fabrazyme

Before using Fabrazyme, tell your doctor if you have

had an allergic reaction to agalsidase beta or have antibodies to the medication; or

heart problems.

You may not be able to use Fabrazyme, or you may require a dosage adjustment or special monitoring during treatment.

Fabrazyme is in the FDA pregnancy category B. This means that it is not expected to be harmful to an unborn baby. Do not use this medication without first talking to your doctor if you are pregnant or could become pregnant during treatment. It is not known whether Fabrazyme passes into breast milk. Do not use this medication without first talking to your doctor if you are breast-feeding a baby.

How should I use Fabrazyme?

Use Fabrazyme exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.

Fabrazyme is given by intravenous (into the vein) injection and will most likely be administered by a healthcare provider.

Your doctor may want you to have blood tests or other medical evaluations during treatment with Fabrazyme to monitor progress and side effects.

Your healthcare provider will store Fabrazyme as instructed by the manufacturer. If you are storing this medication at home, your healthcare provider will give you instructions regarding how to store the medication.

What happens if I miss a dose?

Contact your doctor if you miss a dose of Fabrazyme.

What happens if I overdose?

Contact your doctor, a hospital emergency room, or a poison control center if an overdose is suspected.

Although symptoms of an Fabrazyme overdose are not known, an overdose is unlikely to threaten life.

What should I avoid while taking Fabrazyme?

There are no restrictions on food, beverages, or activity during treatment with Fabrazyme.

Fabrazyme side effects

Symptoms of allergic or infusion reactions including difficulty breathing; closing of the throat; hives; rash; itching; fever; shaking; chest tightness; high or low blood pressure; fast heartbeats; muscle pain; stomach pain; nausea or vomiting; dizziness; numbness or tingling; and headache have occurred upon injection of Fabrazyme in many patients. Most patients treated with Fabrazyme develop antibodies to Fabrazyme and many will develop symptoms of an infusion reaction. A slow rate of injection of the medication and pretreatment with other medications may decrease the severity of these symptoms. Emergency medical attention may be required if a severe allergic reaction is experienced.

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Fabrazyme?

Fabrazyme is not known to interact with other medications. Talk to your doctor or pharmacist before taking other prescription or over-the-counter medications, including herbal products, during treatment with Fabrazyme.

Elaprase

Elaprase

Generic Name: idursulfase (EYE dur SUL fase)

What is Elaprase?

Elaprase is used to treat some of the symptoms of a genetic condition called Hunter’s syndrome. Hunter syndrome is also called mucopolysaccharidosis (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis).

Hunter syndrome is a metabolic disorder in which the body lacks the enzyme needed to break down certain sugars and proteins. These substances can build up in the body, causing enlarged organs, abnormal bone structure, changes in facial features, breathing problems, heart problems, vision loss, and changes in mental or physical abilities.

Elaprase may improve walking ability in people with this condition. However, this medication is not a cure for Hunter syndrome.

Elaprase may also be used for purposes not listed in this medication guide.

Important information about Elaprase

Elaprase may improve walking ability in people with Hunter syndrome. However, Elaprase is not a cure for this condition. Some people receiving an Elaprase injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, light-headed, or have hives, seizure (convulsions), trouble breathing, or swelling of your face, lips, tongue, or throat.

It may still be possible for you to receive Elaprase even after you have had a reaction to it. There are other medications that can be given to you before your Elaprase infusion to help prevent any reaction symptoms.

You may be more likely to have a reaction to Elaprase if you have a breathing disorder. Tell your doctor if you have asthma or other lung disease.

Your name may need to be listed on a Hunter Outcome Survey while you are using this medication. The purpose of this registry is to track the progression of this disorder and the effects that Elaprase has on long-term treatment of Hunter syndrome.

Before receiving Elaprase

You should not receive this medication if you are allergic to idursulfase.

Before receiving Elaprase, tell your doctor if you are allergic to any drugs, or if you have asthma or other breathing disorder.

You may be more likely to have a reaction to Elaprase if you have a breathing disorder. You may need to receive other medications to prevent an symptoms of a reaction to Elaprase. Follow your doctor’s instructions.

Your name may need to be listed on a Hunter Outcome Survey while you are using this medication. The purpose of this registry is to track the progression of this disorder and the effects that Elaprase has on long-term treatment of Hunter syndrome.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether Elaprase passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How is Elaprase given?

Elaprase is given as an injection through a needle placed into a vein. You will most likely receive this injection in a clinic or hospital setting. Elaprase is usually given once per week.

The medicine must be given slowly through an IV infusion, and can take up to 3 hours to complete.

What happens if I miss a dose?

Call your doctor if you miss an appointment for your Elaprase injection.

What happens if I overdose?

Seek emergency medical attention if you think you have received too much of this medicine.

Symptoms of an Elaprase overdose are not known.

What should I avoid while receiving Elaprase?

Follow your doctor’s instructions about any restrictions on food, beverages, or activity while you are receiving Elaprase.

Elaprase side effects

Some people receiving a Elaprase injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, light-headed, or have hives, seizure (convulsions), trouble breathing, or swelling of your face, lips, tongue, or throat.

It may still be possible for you to receive Elaprase even after you have had a reaction to it. There are other medications that can be given to you before your Elaprase infusion to help prevent any reaction symptoms.

Call your doctor at once if you have any of these serious side effects:

worsened asthma;

uneven heartbeats;

blue lips or fingernails;

fever;

vision problems; or

increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure).

Less serious side effects may include:

joint pain;

pain in your arms or legs;

headache;

itching, mild skin rash; or

weakness.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect.

What other drugs will affect Elaprase?

There may be other drugs that can interact with Elaprase. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

Cerezyme

Cerezyme

Generic Name: imiglucerase (im ih GLUE ker ase)

What is Cerezyme?

Cerezyme is a man-made form of the naturally-occurring protein beta-glucocerebrosidase. A deficiency of beta-glucocerebrosidase is called Gaucher disease.

Cerezyme is used for the treatment of Type 1 Gaucher disease that results in one or more of the following: anemia (low level of red blood cells), thrombocytopenia (low level of platelets), bone disease, hepatomegaly (enlargement of the liver), or splenomegaly (enlargement of the spleen).

Cerezyme may also be used for purposes other than those listed here.

Important information about Cerezyme

Symptoms of allergic reactions including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; hives; itching; flushing; and dizziness or fainting, have occurred with the use of Cerezyme. Approximately 15% of patients treated with Cerezyme develop antibodies to imiglucerase. Approximately 46% of patients with detectable antibodies have experienced an allergic reaction. Emergency medical attention may be required if an allergic reaction is experienced.

Before using Cerezyme

Before using Cerezyme, tell your doctor if you have

had an allergic reaction to imiglucerase, alglucerase (Ceredase), or have antibodies to either medication; or

breathing problems or pulmonary hypertension.

You may not be able to use Cerezyme, or you may require a dosage adjustment or special monitoring during treatment.

Cerezyme is in the FDA pregnancy category C. This means that it is not known whether it will be harmful to an unborn baby. Do not use Cerezyme without first talking to your doctor if you are pregnant or could become pregnant during treatment. It is not known whether Cerezyme passes into breast milk. Do not use Cerezyme without first talking to your doctor if you are breast-feeding a baby.

How should I use Cerezyme?

Use Cerezyme exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.

Cerezyme is given by intravenous (into the vein) injection and will most likely be administered by a healthcare provider.

Your doctor may want you to have blood tests or other medical evaluations during treatment with Cerezyme to monitor progress and side effects.

Your healthcare provider will store Cerezyme as instructed by the manufacturer. If you are storing Cerezyme at home, your healthcare provider will give you instructions regarding how to store the medicine.

What happens if I miss a dose?

Contact your doctor if you miss a dose of Cerezyme.

What happens if I overdose?

Contact your doctor, a hospital emergency room, or a poison control center if an overdose is suspected.

Although symptoms of an Cerezyme overdose are not known, an overdose is unlikely to threaten life.

What should I avoid while taking Cerezyme?

There are no restrictions on food, beverages, or activity during treatment with Cerezyme.

Cerezyme side effects

Symptoms of allergic reactions including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; hives; itching; flushing; and dizziness or fainting, have occurred with the use of Cerezyme. Approximately 15% of patients treated with Cerezyme develop antibodies to imiglucerase. Approximately 46% of patients with detectable antibodies have experienced an allergic reaction. Emergency medical attention may be required if an allergic reaction is experienced.

Talk to your doctor if you experience any of the following less serious side effects:

discomfort, burning, itching, swelling, or abscess (open wound or sore) at the injection site;

nausea or vomiting;

abdominal pain;

diarrhea;

fatigue;

headache;

dizziness; or

rash.

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Cerezyme?

Cerezyme is not expected to interact with other medications. Talk to your doctor or pharmacist before taking other prescription or over-the-counter medications, including herbal products, during treatment with Cerezyme.

Aldurazyme

Aldurazyme

Generic Name: laronidase (lah RAH nih daze)

What is Aldurazyme?

Aldurazyme (laronidase) is used to treat some of the symptoms of a genetic condition called Hurler syndrome. Hurler syndrome is also called mucopolysaccharidosis (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis).

Hurler syndrome is a metabolic disorder in which the body lacks the enzyme needed to break down certain sugars and proteins. These substances can build up in the body, causing enlarged organs, abnormal bone structure, changes in facial features, breathing problems, heart problems, vision or hearing loss, and changes in mental or physical abilities.

Aldurazyme may improve breathing and walking ability in people with this condition. However, this medication is not a cure for Hurler syndrome.

Aldurazyme may also be used for other purposes not listed in this medication guide.

Important information about Aldurazyme

Aldurazyme may improve breathing and walking ability in people with Hurler syndrome. However, Aldurazyme is not a cure for this condition. Some people receiving a Aldurazyme injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you have a headache, skin rash or itching, warmth or tingly feeling, or trouble breathing when Aldurazyme is injected.

Your name may need to be listed on a patient registry while you are using Aldurazyme. The purpose of this registry is to track the progression of this disorder and the effects that Aldurazyme has on long-term treatment of Hurler syndrome.

Before receiving Aldurazyme

You should not use this medication if you are allergic to laronidase.

Before using Aldurazyme, tell your doctor if you are allergic to any drugs.

Your name may need to be listed on a patient registry while you are using this medication. The purpose of this registry is to track the progression of this disorder and the effects that Aldurazyme has on long-term treatment of Hurler syndrome.

FDA pregnancy category B. Aldurazyme is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether this medication passes into breast milk or if it could harm a nursing baby. Do not use Aldurazyme without telling your doctor if you are breast-feeding a baby.

How should I use Aldurazyme?

Aldurazyme is given as an injection through a needle placed into a vein. You will most likely receive this injection in a clinic or hospital setting. Aldurazyme is usually given once per week.

The medicine must be given slowly through an IV infusion, and can take up to 4 hours to complete.

Your doctor may also prescribe other medications to help prevent an allergic reaction to Aldurazyme. Take all of your medications as directed.

To be sure Aldurazyme is helping your condition and not causing harmful effects, your doctor will need to check your progress on a regular basis. Do not miss any scheduled appointments.

What happens if I miss a dose?

Contact your doctor if you miss an appointment for your Aldurazyme injection.

What happens if I overdose?

Seek emergency medical attention if you think you have received too much of this medicine.

Symptoms of a Aldurazyme overdose are not known.

What should I avoid while receiving Aldurazyme?

Follow your doctor’s instructions about any restrictions on food, beverages, or activity while you are receiving Aldurazyme.

Aldurazyme side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Some people receiving a Aldurazyme injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you have a headache, skin rash or itching, warmth or tingly feeling, or trouble breathing when Aldurazyme is injected.

Less serious side effects may include:

runny or stuffy nose, sore throat, cough;

mild skin rash;

numbness or tingling; or

pain, redness, swelling, or other irritation where the medicine was injected.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Aldurazyme?

There may be other drugs that can interact with Aldurazyme. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

Free T-Mobile phones on sale | Thanks to Best Savings Accounts, Conveyancing Fees and Used Cars